Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary …
C Vicentini, C Festuccia, GL Gravina… - Journal of cancer …, 2003 - Springer
Purpose. To investigate the effects of the epidermal growth factor receptor tyrosine kinase
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary …
C Vicentini, C Festuccia, GL Gravina… - Journal of Cancer …, 2003 - europepmc.org
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor
tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures. - Abstract …
tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures. - Abstract …
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary …
C Vicentini, C Festuccia, GL Gravina… - Journal of cancer …, 2003 - pubmed.ncbi.nlm.nih.gov
Purpose To investigate the effects of the epidermal growth factor receptor tyrosine kinase
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary …
C Vicentini, C Festuccia, GL Gravina… - Journal of Cancer …, 2003 - search.proquest.com
Purpose. To investigate the effects of the epidermal growth factor receptor tyrosine kinase
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary …
C Vicentini, C Festuccia, GL Gravina… - Journal of Cancer …, 2003 - infona.pl
Purpose.. To investigate the effects of the epidermal growth factor receptor tyrosine kinase
inhibitor (EGFR-TKI) ZD1839 (Iressa) on the cellular proliferation of androgen-sensitive and …
inhibitor (EGFR-TKI) ZD1839 (Iressa) on the cellular proliferation of androgen-sensitive and …
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary …
C Vicentini, C Festuccia, GL Gravina… - Journal of Cancer …, 2003 - elibrary.ru
Purpose.. To investigate the effects of the epidermal growth factor receptor tyrosine kinase
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
[PDF][PDF] Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and …
C Vicentini, C Festuccia, GL Gravina… - J Cancer Res Clin …, 2003 - academia.edu
Purpose: To investigate the effects of the epidermal growth factor receptor tyrosine kinase
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
[引用][C] Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and …
C VICENTINI, C FESTUCCIA… - Journal of cancer …, 2003 - pascal-francis.inist.fr
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor
tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures CNRS …
tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures CNRS …
[PDF][PDF] Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and …
C Vicentini, C Festuccia, GL Gravina… - J Cancer Res Clin …, 2003 - academia.edu
Purpose: To investigate the effects of the epidermal growth factor receptor tyrosine kinase
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …
inhibitor (EGFR-TKI) ZD1839 ('Iressa') on the cellular proliferation of androgen-sensitive and …